Fulbright Fellow & Cambridge PhD Reject Turned Full-Time Investor | All-In On AI Infrastructure | Stocks That Can Double In 12 Months | MA @Dartmouth | NFA
I am raising my $HIMS price target to $150 from $70 for the next 12 months. My 2030 PT is $1000. I believe that this company is the next $PLTR of healthcare.